Parkinson's Disease

팔로우
Illustration of author Rachel Reid at her desk, announcing delay of 'Unrivaled' book due to Parkinson's, with calendar, novels, and Instagram phone.
AI에 의해 생성된 이미지

Rachel Reid delays Unrivaled book to June 2027 for health reasons

AI에 의해 보고됨 AI에 의해 생성된 이미지

Author Rachel Reid has postponed the release of her novel Unrivaled from September 2026 to June 1, 2027, citing worsening Parkinson's symptoms and demands from recent fame. The book is the seventh in her Game Changers series and the third focused on hockey rivals Shane Hollander and Ilya Rozanov. Reid announced the delay in an Instagram video, emphasizing her commitment to quality.

People with Parkinson's disease experience reduced enjoyment from pleasant smells like lemon, according to a new study. This difference in smell perception could help diagnose the condition earlier and more simply. Researchers found that brain processing of scents varies in those affected, distinguishing them from others with smell loss.

AI에 의해 보고됨

Author Rachel Reid has postponed the publication of her upcoming book 'Unrivaled' from September 2026 to June 1, 2027, citing worsening Parkinson's symptoms and a busy schedule following the success of the 'Heated Rivalry' TV adaptation. The novel is the seventh in her 'Game Changers' series and the third focused on characters Shane Hollander and Ilya Rozanov. Reid shared the news in an Instagram video on February 24, 2026, assuring fans the delay will result in a better book.

Scientists have identified a key cellular regulator called PP2A-B55alpha that balances mitochondrial health, potentially leading to new therapies for Parkinson's disease. In preclinical models, reducing its activity improved motor symptoms and mitochondrial function. The findings, published in Science Advances, could extend to other mitochondrial disorders and cancer.

AI에 의해 보고됨

Scientists have developed a blood-based test that detects Parkinson's disease up to seven years before the onset of symptoms. The test targets abnormal alpha-synuclein proteins and shows high accuracy in at-risk individuals. This breakthrough could enable earlier treatments to slow disease progression.

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부